Fig. 1 · Structure
Documents & Downloads
ITX 4520
Hepatitis C Virus Inhibitor
ITX 4520 is a potent inhibitor of the hepatitis C virus (HCV) that operates through a specific mechanism targeting viral replication. This compound demonstrates favorable pharmacokinetic properties in both rat and dog models, making it a promising candidate for further exploration in antiviral research. ITX 4520 is primarily utilized in studies aimed at understanding HCV mechanisms and developing therapeutic strategies against hepatitis C infection.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1392116-37-8 |
| Applications | Hepatitis C Virus Inhibitor |
| Formula | C24H23F2N3OS |
| Molecular Weight | 439.52 |
| SMILES | CC1=NOC(C2=CC3=C(N(CCCSC4=CC(F)=CC(F)=C4)C5=C3CCCC5)C=C2)=N1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.